Summary

Vaccines Market Size, Share, and Analysis, By Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, and mRNA), By Type (Monovalent and Multivalent), By Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, and RSV), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW
Vaccines Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 66.4 billion and is projected to reach USD 122.8 billion by the completion of 2034.
Vaccines are biological preparations designed to boost the immune system and protect against infectious diseases. They consist of weakened or inactivated versions of disease-causing pathogens, such as viruses or bacteria, or components of these agents. When vaccines are administered, the body's immune system identifies the unfamiliar elements and generates antibodies and other active measures to fight against them. This method prepares the immune system to react efficiently in case of future exposure to the real pathogen, thereby averting or reducing the severity of the disease. Therefore, vaccinations are among the most effective public health measures, which annually save millions of lives by averting various diseases such as polio, measles, flu, and most recently, COVID-19.

MARKET HIGHLIGHTS
Vaccine market is projected to reach USD 122.8 billion over the forecast period, due to several factors such as the COVID-19 pandemic, various breakthroughs in technology, and growing awareness of the importance of immunization. Industry players are heavily invested in research and development, which leads to the introduction of new vaccines targeting a wide range of infectious diseases. In addition, the vaccine market has witnessed a rise in demand for COVID-19 vaccines, with companies like Pfizer, Moderna, and AstraZeneca playing important roles in their development and distribution. Besides, the resurgence of infectious diseases like influenza and the growing incidences of chronic diseases have generated the need for preventive measures. Furthermore, collaborations between pharma companies and government agencies have assisted in the development of new vaccine candidates.
Vaccines Market Segments:

• By Technology
o Conjugate
o Recombinant
o Live Attenuated
o Toxoid
o Viral Vector
o mRNA
• By Type
o Monovalent
o Multivalent
• By Disease
o Pneumococcal
o Flu
o HPV
o Herpes Zoster
o MMR
o Rotavirus
o RSV
• By Route of Administration
o Parenteral
o Oral
MARKET DYNAMICS
Growth Drivers
Innovations in Medical Technology Fuels the Growth of Vaccines Market
Growing Awareness and Government Efforts are Promoting the Need for Vaccines
Restraint
Vaccine Hesitancy and Misinformation in the Vaccines Market

Key Players
• Pfizer
• GlaxoSmithKline (GSK)
• Merck & Co.
• Sanofi Pasteur
• Serum Institute of India
• AstraZeneca
• Novavax
• Moderna
• Johnson & Johnson
• CSL Limited
• Bharat Biotech
• Sinovac Biotech
• CanSino Biologics
• Dynavax Technologies
• Valneva
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)


Global Laboratory Temperature Control Units Market is further segmented by region into:
• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA


Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3.Vaccines Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Vaccines Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Vaccines Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Vaccines Market
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Vaccines Market Size & Forecast 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Technology
11.3.1.1. Conjugate
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2.Market Share (%) 2024-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Recombinant
11.3.1.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3.Live Attenuated
11.3.1.3.1.By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.4.Toxoid
11.3.1.4.1.By Value (USD Million) 2024-2034F
11.3.1.4.2. Market Share (%) 2024-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.5.Viral Vector
11.3.1.5.1.By Value (USD Million) 2024-2034F
11.3.1.5.2. Market Share (%) 2024-2034F
11.3.1.5.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.6.mRNA
11.3.1.6.1.By Value (USD Million) 2024-2034F
11.3.1.6.2. Market Share (%) 2024-2034F
11.3.1.6.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Type
11.3.2.1.Monovalent
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Multivalent
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By Disease
11.3.3.1.Pneumococcal
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Flu
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.3. HPV
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2.Market Share (%) 2024-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Herpes Zoster
11.3.3.4.1. By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.5. MMR
11.3.3.5.1. By Value (USD Million) 2024-2034F
11.3.3.5.2.Market Share (%) 2024-2034F
11.3.3.5.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.6. Rotavirus
11.3.3.6.1. By Value (USD Million) 2024-2034F
11.3.3.6.2.Market Share (%) 2024-2034F
11.3.3.6.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.7. RSV
11.3.3.7.1. By Value (USD Million) 2024-2034F
11.3.3.7.2.Market Share (%) 2024-2034F
11.3.3.7.3.Y-o-Y Growth (%) 2024-2034F
11.3.4. By Route of Administration
11.3.4.1.Parenteral
11.3.4.1.1.By Value (USD Million) 2024-2034F
11.3.4.1.2. Market Share (%) 2024-2034F
11.3.4.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.2. Oral
11.3.4.2.1. By Value (USD Million) 2024-2034F
11.3.4.2.2.Market Share (%) 2024-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F
12. North America Vaccines Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Technology
12.3.2.By Type
12.3.3.By Disease
12.3.4.By Route of Administration
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Vaccines Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Technology
13.3.2.By Type
13.3.3.By Disease
13.3.4.By Route of Administration
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Vaccines Market Size & Forecast 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Technology
14.3.2.By Type
14.3.3.By Disease
14.3.4. By Route of Administration
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Vaccines Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Technology
15.3.2.By Type
15.3.3.By Disease
15.3.4.By Route of Administration
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4.South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Vaccines Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Technology
16.3.2.By Type
16.3.3.By Disease
16.3.4.By Route of Administration
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.Pfizer
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.GlaxoSmithKline (GSK)
18.3.Merck & Co.
18.4.Sanofi Pasteur
18.5.Serum Institute of India
18.6.AstraZeneca
18.7.Novavax
18.8.Moderna
18.9.Johnson & Johnson
18.10.CSL Limited
18.11. Bharat Biotech
18.12.Sinovac Biotech
18.13.CanSino Biologics
18.14.Dynavax Technologies
18.15.Valneva
18.16.Other Prominent Players
19. Appendix
20.Consultant Recommendation